Parsons Stock Gains 49 percent in a Year What Should Investors Do Now?
| CDLX Stock | USD 3.06 0.10 3.16% |
Slightly above 72% of Cardlytics' investor base is looking to short. The current sentiment regarding investing in Cardlytics stock implies that many traders are alarmed. Cardlytics' investing sentiment can be driven by a variety of factors including economic data, Cardlytics' earnings reports, geopolitical events, and overall market trends.
Cardlytics |
Given the recent rise in PSN shares, we analyze its current position to determine whether you should buy, hold or sell it.
Read at zacks.com
 |
Cardlytics Fundamental Analysis
We analyze Cardlytics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardlytics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardlytics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Cardlytics is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Cardlytics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cardlytics stock to make a market-neutral strategy. Peer analysis of Cardlytics could also be used in its relative valuation, which is a method of valuing Cardlytics by comparing valuation metrics with similar companies.
Peers
Cardlytics Related Equities
| MCHX | Marchex | 1.00 | ||||
| OMC | Omnicom | 0.31 | ||||
| CRTO | Criteo Sa | 0.03 | ||||
| IAS | Integral | 0.00 | ||||
| IPG | Interpublic Group | 0.14 | ||||
| CTV | Innovid Corp | 0.32 | ||||
| DLX | Deluxe | 0.98 | ||||
| BOC | Boston Omaha | 1.29 | ||||
| EEX | Emerald Expositions | 2.81 | ||||
| ADV | Advantage Solutions | 2.94 | ||||
| QNST | QuinStreet | 3.19 | ||||
| CMPR | Cimpress | 5.25 |
Additional Tools for Cardlytics Stock Analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.